Fossil’s latest smartwatch is set to integrate Cardiogram, an app that uses deep neural network technology to detect various heart conditions, preinstalled. The Cardiogram platform has been tested to detect sleep apnea, diabetes, hypertension and atrial fibrillation.
Typically, Cardiogram Care is included only in Cardiogram’s premium version, which costs $15 a month. However, the Cardiogram Care...
Designer brand Kate Spade announced its first line of connected activity-tracking wearables last week. The three-item collection –a jewelry-inspired bangle, smartwatch and silicone tracker – are the product of Kate Spade’s partnership with Fossil Group, which recently announced its primary focus on connected wearables as a way to get back into fighting shape against competitors like Fitbit and...
Over the years, more and more companies have gone public in the digital health space and existing public companies have gotten into the space, either on their own or thorugh acquisitions. Here's a roundup of digital health talk on the latest round of second quarter investor calls and quarterly finance reports.
Fitbit. San Francisco-based Fitbit, maker of a series of popular wearable activity...
In an effort to turn around the consistent declining revenue and sales, watchmaker Fossil Group is shifting its focus to smartwatches and trackers, effectively trying to rebrand itself as the leader in the industry by embarking on what executives called an “unprecedented launch.”
During a second quarter earnings call with investors and analysts, Fossil CEO Kosta Kartsotis said over the next three...
Fossil announced a new activity and sleep tracking wearable at SXSW last week, the Q Motion. Though the design is slightly different, the wrist-worn device is almost a dead-ringer for the Misfit Ray, the most recent device unveiled by Misfit, the wearable company Fossil acquired in November.
Like the Misfit Ray, the Q Motion tracks activity and sleep and can vibrate with call or text...
Considering recent events, big name consumer brands are more likely than ever to move into regulated medical devices.
Two weeks ago Apple CEO Tim Cook told a newspaper that while his company wouldn't put the Apple Watch through the motions of an FDA clearance process, Cook "wouldn't mind putting something adjacent to the watch through it." He said that before adding maybe that'd be an app or...
